News Tag: Other Corporate Information

Careium AB signs an agreement with a municipality in Skåne regarding the medication robot Dosell

iZafe Group hereby announces that the partner Careium AB has signed an agreement with a municipality in Skåne, which has chosen to introduce the Swedish made medication robot Dosell in its operations.

“We are now starting to see more municipalities choosing to see how Dosell can be the choice of medication robot for implementation in their operations. We welcome Careium AB's first municipality, which is a direct result of the fact that they have now taken the step into a sales phase. We are very expectant for 2022”. Says Tobias Johansson, VP, iZafe Group.

Contacts

Carl-Fredrik Bothén, Chief Marketing Officer
E-mail:
Phone number: +46 73-064 48 67

Anders Segerström, Chief Executive Officer 
E-mail:
Phone number: +46 70-875 14 12

iZafe Group AB (publ.)
Södra Fiskartorpsvägen 20
114 33 Stockholm

E-mail: 
www.izafe.se/investor-relations/

About Us

iZafe Group is a Swedish Life-Science company that develops and markets medical and digital security solutions to create safer drug handling at home. The company’s digital medication dispenser Dosell reduces the risk of incorrect medication, increases security for family and relatives and relieves public care personnel. The products form a holistic concept that facilitates patient medication and gives those who are treated at home better conditions for a happy and safe life. Customers today consist of public and private care providers in Sweden, the Nordic countries and globally. iZafe Group sells primarily through well-established partners who already have long and deep customer relationships with the priority customer groups. The head office is located in Stockholm.

The company is listed on the NASDAQ First North Premier Growth Market. FNCA Sweden AB is the company's Certified Adviser. Phone: +46 (0) 8 528 00 399. E-mail: . Further information is available at www.izafe.se/investor-relations/.

Attachments

Careium AB signs an agreement with a municipality in Skåne regarding the medication robot Dosell

Careium AB signs an agreement with a municipality in Skåne regarding the medication robot Dosell

iZafe Group AB, summary of 2021 from the CEO

A video summary from Anders Segerström CEO iZafe Group AB of the year 2021 and an insight into 2022.

Here is a summary of the past year 2021 and an insight into 2022 from Anders Segerström, CEO of iZafe. Click on the link HERE to watch the movie.

Contacts

Carl-Fredrik Bothén, Chief Marketing Officer
E-mail:
Phone number: +46 73-064 48 67

Anders Segerström, Chief Executive Officer 
E-mail:
Phone number: +46 70-875 14 12

iZafe Group AB (publ.)
Södra Fiskartorpsvägen 20
114 33 Stockholm

E-mail: 
www.izafe.se/investor-relations/

About Us

iZafe Group is a Swedish Life-Science company that develops and markets medical and digital security solutions to create safer drug handling at home. The company’s digital medication dispenser Dosell reduces the risk of incorrect medication, increases security for family and relatives and relieves public care personnel. The products form a holistic concept that facilitates patient medication and gives those who are treated at home better conditions for a happy and safe life. Customers today consist of public and private care providers in Sweden, the Nordic countries and globally. iZafe Group sells primarily through well-established partners who already have long and deep customer relationships with the priority customer groups. The head office is located in Stockholm.

The company is listed on the NASDAQ First North Premier Growth Market. FNCA Sweden AB is the company's Certified Adviser. Phone: +46 (0) 8 528 00 399. E-mail: . Further information is available at www.izafe.se/investor-relations/.

Attachments

iZafe Group AB, summary of 2021 from the CEO

iZafe Group AB, summary of 2021 from the CEO

iZafe Group holds a partner interview with Norwegian Hepro AS

iZafe Group AB has held a partner interview between Anders Segerström, CEO of iZafe Group AB and Geir Tore Jakobsen, CEO of Hepro AS.

In the interview between the companies, we clarify certain issues posed to us and at the same time we provide an insight into the future of the medication robot Dosell on the Norwegian market. Link to the intervju Click HERE
 
HEPRO AS is a modern and future-oriented competence company that develops, produces and sells aids and welfare technology of high quality and clean design. The company was founded in 1987 and has extensive experience in developing products and solutions that will make everyday life easier for their customers. Their vision is to give their customers the opportunity to manage themselves, participate actively in their own everyday lives and stay longer at home. Hepro is owned by the Stockholm-based listed AddLife Group. AddLife has approx. 70 st. independent subsidiaries and over 1800 employees.

Contacts

Carl-Fredrik Bothén, Chief Marketing Officer
E-mail:
Phone number: +46 73-064 48 67

Anders Segerström, Chief Executive Officer 
E-mail:
Phone number: +46 70-875 14 12

iZafe Group AB (publ.)
Södra Fiskartorpsvägen 20
114 33 Stockholm

E-mail: 
www.izafe.se/investor-relations/

About Us

iZafe Group is a Swedish Life-Science company that develops and markets medical and digital security solutions to create safer drug handling at home. The company’s digital medication dispenser Dosell reduces the risk of incorrect medication, increases security for family and relatives and relieves public care personnel. The products form a holistic concept that facilitates patient medication and gives those who are treated at home better conditions for a happy and safe life. Customers today consist of public and private care providers in Sweden, the Nordic countries and globally. iZafe Group sells primarily through well-established partners who already have long and deep customer relationships with the priority customer groups. The head office is located in Stockholm.

The company is listed on the NASDAQ First North Premier Growth Market. FNCA Sweden AB is the company's Certified Adviser. Phone: +46 (0) 8 528 00 399. E-mail: . Further information is available at www.izafe.se/investor-relations/.

Attachments

iZafe Group holds a partner interview with Norwegian Hepro AS

iZafe Group holds a partner interview with Norwegian Hepro AS

Careium AB places order for 40 Dosell, a Swedish made medication robot.

iZafe Group hereby announces that Careium AB, formerly Doro Care, is ordering forty Dosell medication robots.

"It's fun to work with some of the best in automated medication dosing. Dosell will free up more time for patient contact during home visits and play a crucial role in improving the quality of life for home care customers." says Nikola Josevski, Project Manager Careium AB

Careium formerly Doro Care is the market leader with new innovation in Sweden and Norway and one of the leading players in the UK and the Netherlands. This position means that Careium is one of the leading players in Europe that provides welfare technology services. Careium's innovative solutions improve the safety, quality of life and independence of seniors both inside and outside the home. For the care provider, the company's solutions mean increased efficiency and the opportunity to invest resources in more valuable activities. Careium is one of the few players that can offer the entire chain with security alarms, sensors (fall sensors, smoke detectors, motion detectors, etc.), accessories (cameras, electronic locks, medication robots, etc.) and secure communication with alarm reception: the company provides a complete digital alarm chain.

Contacts

Carl-Fredrik Bothén, Chief Marketing Officer
E-mail:
Phone number: +46 73-064 48 67

Anders Segerström, Chief Executive Officer 
E-mail:
Phone number: +46 70-875 14 12

iZafe Group AB (publ.)
Södra Fiskartorpsvägen 20
114 33 Stockholm

E-mail: 
www.izafe.se/investor-relations/

About Us

iZafe Group is a Swedish Life-Science company that develops and markets medical and digital security solutions to create safer drug handling at home. The company’s digital medication dispenser Dosell reduces the risk of incorrect medication, increases security for family and relatives and relieves public care personnel. The products form a holistic concept that facilitates patient medication and gives those who are treated at home better conditions for a happy and safe life. Customers today consist of public and private care providers in Sweden, the Nordic countries and globally. iZafe Group sells primarily through well-established partners who already have long and deep customer relationships with the priority customer groups. The head office is located in Stockholm.

The company is listed on the NASDAQ First North Premier Growth Market. FNCA Sweden AB is the company's Certified Adviser. Phone: +46 (0) 8 528 00 399. E-mail: . Further information is available at www.izafe.se/investor-relations/.

Attachments

Careium AB places order for 40 Dosell, a Swedish made medication robot.

Careium AB places order for 40 Dosell, a Swedish made medication robot.

The municipality of Söderköping is extending the agreement with Zafe Care Systems AB and the Swedish-made Pharmaceutical Robot Dosell from iZafe Group.

Stockholm, Sweden – iZafe Group AB (publ.) (NASDAQ First North: IZAFE B) – hereby announces that the Municipality of Söderköping is extending the agreement by 12 months and our partner Zafe Care Systems AB.

Söderköping continues its work with digitization of the home care service and has now chosen to continue with the pharmaceutical robot Dosell. The agreement was initially signed in 2018.

Contacts

Carl-Fredrik Bothén, Chief Marketing Officer
E-mail:
Phone number: +46 73-064 48 67

Anders Segerström, Chief Executive Officer 
E-mail:
Phone number: +46 70-875 14 12

iZafe Group AB (publ.)
Södra Fiskartorpsvägen 20
114 33 Stockholm

E-mail: 
www.izafe.se/investor-relations/

About Us

iZafe Group is a Swedish Life-Science company that develops and markets medical and digital security solutions to create safer drug handling at home. The company’s digital medication dispenser Dosell reduces the risk of incorrect medication, increases security for family and relatives and relieves public care personnel. The products form a holistic concept that facilitates patient medication and gives those who are treated at home better conditions for a happy and safe life. Customers today consist of public and private care providers in Sweden, the Nordic countries and globally. iZafe Group sells primarily through well-established partners who already have long and deep customer relationships with the priority customer groups. The head office is located in Stockholm.

The company is listed on the NASDAQ First North Premier Growth Market. FNCA Sweden AB is the company's Certified Adviser. Phone: +46 (0) 8 528 00 399. E-mail: . Further information is available at www.izafe.se/investor-relations/.

Attachments

The municipality of Söderköping is extending the agreement with Zafe Care Systems AB and the Swedish-made Pharmaceutical Robot Dosell from iZafe Group.

The municipality of Söderköping is extending the agreement with Zafe Care Systems AB and the Swedish-made Pharmaceutical Robot Dosell from iZafe Group.

iZafe Group releases report on pharmaceutical use.

Stockholm, Sweden – iZafe Group AB (publ.) (NASDAQ First North: IZAFE B) – releases "Nobody wants to take the wrong medicine" (only available in Swedish) a report on pharmaceutical use and safety in medication. The report was made in connection with the market research at the launch of Dosell Consumer.

Every year, 6.7 million Swedes take prescription medicine, according to the National Board of Health and Welfare. To take wrong medication at the wrong time or completely forgetting the dose is dangerous for a person that takes multiple pharmaceuticals. The risk of taking the wrong medication becomes a stress factor and gives one a feeling of anxiety. The report reads that 31 per cent mention that they need some kind of help with their medication.

“My father, who takes several medicines daily, saw the benefits of Dosell early on for his own part and he feels a great sense of security in minimizing the risk of missing his prescribed dose. As a relative, I feel calm to receive a confirmation every day that my father has not forgotten his medicine. With the knowledge that 3,000 people decease every year in Sweden as a result of incorrect medication, it feels extremely good to know that I as a relative do what I can to ensure that my own father's medication handling is as safe as it is thanks to Dosell.” Says Ida Almgren, CFO of iZafe Group AB.

Wrong medication is a very dangerous problem in society that does not get enough
attention. It costs both life and suffering for the one who suffers and creates great
concern for relatives. An elderly person who has forgotten to take their medicine is often admitted to hospital. A care day costs SEK 15,000. In total, incorrect medication today costs society SEK 20 billion per year.
 
The attached report shows the results of a survey conducted by the opinion and market research company YouGov on behalf of iZafe Group and Dosell. In 2021, 2063 interviews were conducted with men and women aged 18 and up in Sweden. Data were weighed based on the criteria gender, age and region on the basis of a model from Statistics Sweden.

Contacts

Carl-Fredrik Bothén, Chief Marketing Officer
E-mail:
Phone number: +46 73-064 48 67

Anders Segerström, Chief Executive Officer 
E-mail:
Phone number: +46 70-875 14 12

iZafe Group AB (publ.)
Södra Fiskartorpsvägen 20
114 33 Stockholm

E-mail: 
www.izafe.se/investor-relations/

About Us

iZafe Group is a Swedish Life-Science company that develops and markets medical and digital security solutions to create safer drug handling at home. The company’s digital medication dispenser Dosell reduces the risk of incorrect medication, increases security for family and relatives and relieves public care personnel. The products form a holistic concept that facilitates patient medication and gives those who are treated at home better conditions for a happy and safe life. Customers today consist of public and private care providers in Sweden, the Nordic countries and globally. iZafe Group sells primarily through well-established partners who already have long and deep customer relationships with the priority customer groups. The head office is located in Stockholm.

The company is listed on the NASDAQ First North Premier Growth Market. FNCA Sweden AB is the company's Certified Adviser. Phone: +46 (0) 8 528 00 399. E-mail: . Further information is available at www.izafe.se/investor-relations/.

Attachments

iZafe Group releases report on pharmaceutical use.
Rapport Ingen Vill Ta Fel Medicin

iZafe Group releases report on pharmaceutical use.
Rapport Ingen Vill Ta Fel Medicin

The first Italian version of Dosell was sent today to Sempli Farma in Italy.

Stockholm, Sweden – iZafe Group AB (publ.) (NASDAQ First North: IZAFE B) – hereby announces that the first pharmaceutical robots adapted for the Italian consumer market have now been sent to Sempli Farma in Italy for the pilot project.

In October this year, we communicated the upcoming pilot project in Italy. With a certain delay, we can now announce that the pharmaceutical robots have been sent from Sweden and are expected to be delivered to Sempli Farma next week.
 
All parts such as Dosell, manuals, mobile app, system and brochure are ready and adapted for the Italian market, which means that Sempli Farma has everything to get started.
 
About Sempli Farma by Remedio S.R.L
The Italian healthcare company Remedio has built a network of strategically selected partners in Italy to find a combination of different aids in drug management and distribution channels that enable the elderly to stay at home longer. Unlike in Sweden, the possibility of receiving medicine on a dose roll has not existed in Italy; this has inspired Remedio to launch the concept of sachets and develop the complete solution Sempli Farma.
 
Sempli Farma is a service that connects pharmacists with the patient and their relatives via a pharmacy through a closed system for drug dispensing. The care concept aims to reduce care costs and streamline the Italian healthcare system. Dosell becomes the ultimate end component by delivering the dose bags while at the same time the compliance of the medication can be checked and statistics obtained.

Sempli Farma has grown in 2020 and 2021 through a capital raising of
300,000 euros. The organization has been strengthened with a clinical engineer, a sales manager who works to create an external sales network and a marketing and communications department.

Contacts

Carl-Fredrik Bothén, Chief Marketing Officer
E-mail:
Phone number: +46 73-064 48 67

Anders Segerström, Chief Executive Officer 
E-mail:
Phone number: +46 70-875 14 12

iZafe Group AB (publ.)
Södra Fiskartorpsvägen 20
114 33 Stockholm

E-mail: 
www.izafe.se/investor-relations/

About Us

iZafe Group is a Swedish Life-Science company that develops and markets medical and digital security solutions to create safer drug handling at home. The company’s digital medication dispenser Dosell reduces the risk of incorrect medication, increases security for family and relatives and relieves public care personnel. The products form a holistic concept that facilitates patient medication and gives those who are treated at home better conditions for a happy and safe life. Customers today consist of public and private care providers in Sweden, the Nordic countries and globally. iZafe Group sells primarily through well-established partners who already have long and deep customer relationships with the priority customer groups. The head office is located in Stockholm.

The company is listed on the NASDAQ First North Premier Growth Market. FNCA Sweden AB is the company's Certified Adviser. Phone: +46 (0) 8 528 00 399. E-mail: . Further information is available at www.izafe.se/investor-relations/.

Attachments

The first Italian version of Dosell was sent today to Sempli Farma in Italy.

The first Italian version of Dosell was sent today to Sempli Farma in Italy.

Zafe Care Systems places order for the pharmaceutical robot Dosell.

Stockholm, Sweden – iZafe Group AB (publ.) (NASDAQ First North: IZAFE B) – hereby announces that Zafe Care Systems is ordering 50 Dosell and is now initiating offensive marketing activities to bring the pharmaceutical robot to market.

“We are pleased that our extensive testing of the new Dosell pharmaceutical robot has been successfully completed and look forward to marketing and selling the pharmaceutical robot to our customers. Dosell fits well into our product & service portfolio creating additional security and making it easier for users, care and nursing staff. We see a great demand in the market in welfare technology and initially order 50 Dosell, we are really looking forward to 2022 and its continued future." Says Anders Nilsson, Sales Manager Zafe Care Systems.

 
Zafe Care Systems AB, which was acquired by the AddLife Group, is part of Home Care, similar to Norwegian Hepro, and is one of the leading companies in welfare technology on the Swedish market. Their main customers are the state, municipalities and aid centers. Today, they work with more than 200 municipalities and are suitable thanks to their market-leading technology in all types of care homes.

Contacts

Carl-Fredrik Bothén, Chief Marketing Officer
E-mail:
Phone number: +46 73-064 48 67

Anders Segerström, Chief Executive Officer 
E-mail:
Phone number: +46 70-875 14 12

iZafe Group AB (publ.)
Södra Fiskartorpsvägen 20
114 33 Stockholm

E-mail: 
www.izafe.se/investor-relations/

About Us

iZafe Group is a Swedish Life-Science company that develops and markets medical and digital security solutions to create safer drug handling at home. The company’s digital medication dispenser Dosell reduces the risk of incorrect medication, increases security for family and relatives and relieves public care personnel. The products form a holistic concept that facilitates patient medication and gives those who are treated at home better conditions for a happy and safe life. Customers today consist of public and private care providers in Sweden, the Nordic countries and globally. iZafe Group sells primarily through well-established partners who already have long and deep customer relationships with the priority customer groups. The head office is located in Stockholm.

The company is listed on the NASDAQ First North Premier Growth Market. FNCA Sweden AB is the company's Certified Adviser. Phone: +46 (0) 8 528 00 399. E-mail: . Further information is available at www.izafe.se/investor-relations/.

Attachments

Zafe Care Systems places order for the pharmaceutical robot Dosell.

Zafe Care Systems places order for the pharmaceutical robot Dosell.

iZafe engages Mangold Fondkommission as liquidity provider

iZafe Group AB (”iZafe”) has entered into an agreement with Mangold Fondkommission AB (Mangold) as liquidity provider for the iZafe share on Nasdaq First North Growth Market. The purpose of the liquidity provider is to improve the liquidity of the share and decrease the spread between the ask and bid price. Mangold’s assignment commences on November 30, 2021.

In its assignment as liquidity provider, Mangold will facilitate trade in the iZafe share by continuously maintaining both ask and bid orders in the order book. The purpose is to ensure a more accurate share price, which leads to a more accurate company valuation and improves the trading volume of the share.

Contacts

Carl-Fredrik Bothén, Chief Marketing Officer
E-mail:
Phone number: +46 73-064 48 67

Anders Segerström, Chief Executive Officer 
E-mail:
Phone number: +46 70-875 14 12

iZafe Group AB (publ.)
Södra Fiskartorpsvägen 20
114 33 Stockholm

E-mail: 
www.izafe.se/investor-relations/

About Us

iZafe Group is a Swedish Life-Science company that develops and markets medical and digital security solutions to create safer drug handling at home. The company’s digital medication dispenser Dosell reduces the risk of incorrect medication, increases security for family and relatives and relieves public care personnel. The products form a holistic concept that facilitates patient medication and gives those who are treated at home better conditions for a happy and safe life. Customers today consist of public and private care providers in Sweden, the Nordic countries and globally. iZafe Group sells primarily through well-established partners who already have long and deep customer relationships with the priority customer groups. The head office is located in Stockholm.

The company is listed on the NASDAQ First North Premier Growth Market. FNCA Sweden AB is the company's Certified Adviser. Phone: +46 (0) 8 528 00 399. E-mail: . Further information is available at www.izafe.se/investor-relations/.

Attachments

iZafe engages Mangold Fondkommission as liquidity provider

iZafe engages Mangold Fondkommission as liquidity provider

Commercial new launch of Dosell together with Hepro AS in Norway

Hepro AS has last issued a final approval of the new version of Dosell and has officially approved the pharmaceutical robot in its entirety for the Norwegian market.

“We are pleased that all of our tests on the new Dosell have now been successfully completed and look forward to officially presenting the new improved Dosell to all Norwegian municipalities from now on. In the future, the pharmaceutical robot will be a priority product in Hepro's product portfolio. We can now finally start selling, which we look forward to.” Says Geir Tore Jakobsen CEO, Hepro AS

As Dosell is a medical technology product that requires high security and functionality, all of our partners have had to carry out their own internal controls of hardware and software and ensure all integrations and alarm handling. Following the implementation of the first version of Dosell, some technical challenges arose. The problems caused by the challenges have meant that the requirements for testing and quality assurance have become very high in order for the product to be approved. Dosell has now received this quality stamp and now that Hepro has given its approval, the pharmaceutical robot is now approved for the Scandinavian market.

"These tests have taken longer than the forecast. At the same time, we are very happy to work with such serious partners who make solid own checks to ensure all parts. Hepro AS has been a very important partner for us in the development and testing of Dosell 2.0 and it feels fantastic that the product is now secured at all levels.” Says Anders Segerström, CEO of iZafe Group AB.

Contacts

Carl-Fredrik Bothén, Chief Marketing Officer
E-mail:
Phone number: +46 73-064 48 67

Anders Segerström, Chief Executive Officer 
E-mail:
Phone number: +46 70-875 14 12

iZafe Group AB (publ.)
Södra Fiskartorpsvägen 20
114 33 Stockholm

E-mail: 
www.izafe.se/investor-relations/

About Us

iZafe Group is a Swedish Life-Science company that develops and markets medical and digital security solutions to create safer drug handling at home. The company’s digital medication dispenser Dosell reduces the risk of incorrect medication, increases security for family and relatives and relieves public care personnel. The products form a holistic concept that facilitates patient medication and gives those who are treated at home better conditions for a happy and safe life. Customers today consist of public and private care providers in Sweden, the Nordic countries and globally. iZafe Group sells primarily through well-established partners who already have long and deep customer relationships with the priority customer groups. The head office is located in Stockholm.

The company is listed on the NASDAQ First North Premier Growth Market. FNCA Sweden AB is the company's Certified Adviser. Phone: +46 (0) 8 528 00 399. E-mail: . Further information is available at www.izafe.se/investor-relations/.

Attachments

Commercial new launch of Dosell together with Hepro AS in Norway

Commercial new launch of Dosell together with Hepro AS in Norway
Webbdesign av Comlog Webbyrå Stockholm